Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
ESSA Pharma Inc. (EPIX) had Weighted-Average Shares Outstanding (Diluted) of 44.28M for the most recently reported fiscal year, ending 2024-09-30.
Income Statement Financials | |
-- |
|
$-28.54M |
|
-- |
|
-- |
|
$34.42M |
|
$-34.42M |
|
$5.88M |
|
$-28.54M |
|
$-28.54M |
|
$-28.54M |
|
$-28.54M |
|
$-28.54M |
|
$-28.54M |
|
$-34.42M |
|
$-34.33M |
|
44.28M |
|
Weighted-Average Shares Outstanding (Diluted) |
44.28M |
$-0.64 |
|
$-0.64 |
|
Balance Sheet Financials | |
$127.56M |
|
-- |
|
$0.55M |
|
$128.11M |
|
$3.30M |
|
-- |
|
$0.21M |
|
$3.51M |
|
$124.61M |
|
$124.61M |
|
$124.61M |
|
44.39M |
|
Cash Flow Statement Financials | |
$-22.72M |
|
$91.79M |
|
$0.93M |
|
$33.70M |
|
$103.71M |
|
$70.01M |
|
$6.54M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
38.64 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-22.72M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-22.91% |
|
-22.91% |
|
-22.28% |
|
-22.91% |
|
$2.81 |
|
$-0.51 |
|
$-0.51 |